Crosswalk of the Integrated HIV Prevention and Care Plan Guidance (CY 2016-2021 and CY 2022-2026) and the Ending the HIV Epidemic in the U.S. Program Guidance
Resource updated 09/19/2023
Resource updated 09/19/2023
Resource updated 07/07/2022
Resource updated 08/03/2023
Resource updated 07/07/2022
Resource updated 08/03/2023
Resource updated 09/19/2023
The fourth webinar in our series, Charting the Course for the Next Five Years: 2022-2026 Goals, Objectives, and Strategies, focuses on Section V of the Integrated Plan Guidance - 2022-2026 Goals and Objectives. This section details the "what" and "how" of your Integrated Plan, and will serve as the playbook for health departments, service providers, stakeholders, and people with HIV through 2026. During the webinar, presenters from the West Central Florida Ryan White Care Council
Resource updated 07/07/2022
The third session of our Integrated Planning Webinar and Peer Learning Series focused on Section IV of the Integrated Plan Guidance - Situational Analysis. During the webinar, presenters from IHAP TAC's partner NASTAD 1) reviewed the Situational Analysis requirements, including key differences between the EHE and Integrated Planning situational analysis components and 2) provided lessons learned and recommendations for developing the situational analysis.
Resource updated 08/28/2023
Resource updated 09/19/2023
Resource updated 03/26/2024
Resource updated 09/19/2023
Resource updated 06/06/2023
Resource updated 09/19/2023
Resource updated 04/10/2023
Session on a rural clinic's work and adjustments during COVID-19. Presentation from the Division of Community HIV/AIDS Programs (DCHAP) Business Day Meeting held at the 2022 National Ryan White Conference.
Resource (Conference Presentation) updated 09/14/2023
Significant challenges exist in vaccinating people with HIV for COVID-19. Our RWPC program set out to implement and evaluate a vaccine initiative for COVID-19 for people with HIV. We achieved vaccine rates of 78 percent being fully vaccinated by December 1, 2021 and 30 percent having a third dose.
Resource (Conference Presentation) updated 09/14/2023
Review of rapid ART features to reduce time to ART from 7 to 1.6 days, including pre-visit benefits navigation, manufacturer discount cards, prescribing to in-house pharmacies, email distribution lists, and post-prescriptive follow-up.
Resource (Conference Presentation) updated 09/14/2023
California’s AIDS Drug Assistance Program (ADAP) and Pre-Exposure Prophylaxis Assistance Program (PrEP-AP) provide access to life-saving medications and insurance assistance for eligible California residents living with or at risk of acquiring HIV. This presentation will explore the efficacy of various program policy changes implemented by California during the COVID-19 pandemic.
Resource (Conference Presentation) updated 09/14/2023
Review of a 12-month clinical telePrEP program for rural South Carolina residents, which evaluated the feasibility and acceptability of PrEP delivered through a telehealth model.
Resource (Conference Presentation) updated 09/14/2023